The global Cancer Microbiome market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Next Generation Sequencing Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Cancer Microbiome include CD Genomics, Eurofins Scientific, Illumina, Prescient Medicine Holding, Micronoma, Novogene, Oxford Nanopore Technologies, Pacific Biosciences and Qiagen, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Microbiome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Microbiome. This report contains market size and forecasts of Cancer Microbiome in global, including the following market information:
Global Cancer Microbiome Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Cancer Microbiome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Microbiome Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Cancer Microbiome Market Segment Percentages, by Type, 2023 (%)
Next Generation Sequencing
Polymerase Chain Reaction
Global Cancer Microbiome Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Cancer Microbiome Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinic
Others
Global Cancer Microbiome Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Cancer Microbiome Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Microbiome revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Cancer Microbiome revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
CD Genomics
Eurofins Scientific
Illumina
Prescient Medicine Holding
Micronoma
Novogene
Oxford Nanopore Technologies
Pacific Biosciences
Qiagen
Therma Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Microbiome, market overview.
Chapter 2: Global Cancer Microbiome market size in revenue.
Chapter 3: Detailed analysis of Cancer Microbiome company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Microbiome in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Microbiome Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Microbiome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Microbiome Overall Market Size
2.1 Global Cancer Microbiome Market Size: 2023 VS 2030
2.2 Global Cancer Microbiome Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Microbiome Players in Global Market
3.2 Top Global Cancer Microbiome Companies Ranked by Revenue
3.3 Global Cancer Microbiome Revenue by Companies
3.4 Top 3 and Top 5 Cancer Microbiome Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cancer Microbiome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Microbiome Players in Global Market
3.6.1 List of Global Tier 1 Cancer Microbiome Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Microbiome Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Microbiome Market Size Markets, 2023 & 2030
4.1.2 Next Generation Sequencing
4.1.3 Polymerase Chain Reaction
4.2 By Type - Global Cancer Microbiome Revenue & Forecasts
4.2.1 By Type - Global Cancer Microbiome Revenue, 2019-2024
4.2.2 By Type - Global Cancer Microbiome Revenue, 2025-2030
4.2.3 By Type - Global Cancer Microbiome Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Microbiome Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Cancer Microbiome Revenue & Forecasts
5.2.1 By Application - Global Cancer Microbiome Revenue, 2019-2024
5.2.2 By Application - Global Cancer Microbiome Revenue, 2025-2030
5.2.3 By Application - Global Cancer Microbiome Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cancer Microbiome Market Size, 2023 & 2030
6.2 By Region - Global Cancer Microbiome Revenue & Forecasts
6.2.1 By Region - Global Cancer Microbiome Revenue, 2019-2024
6.2.2 By Region - Global Cancer Microbiome Revenue, 2025-2030
6.2.3 By Region - Global Cancer Microbiome Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cancer Microbiome Revenue, 2019-2030
6.3.2 US Cancer Microbiome Market Size, 2019-2030
6.3.3 Canada Cancer Microbiome Market Size, 2019-2030
6.3.4 Mexico Cancer Microbiome Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Microbiome Revenue, 2019-2030
6.4.2 Germany Cancer Microbiome Market Size, 2019-2030
6.4.3 France Cancer Microbiome Market Size, 2019-2030
6.4.4 U.K. Cancer Microbiome Market Size, 2019-2030
6.4.5 Italy Cancer Microbiome Market Size, 2019-2030
6.4.6 Russia Cancer Microbiome Market Size, 2019-2030
6.4.7 Nordic Countries Cancer Microbiome Market Size, 2019-2030
6.4.8 Benelux Cancer Microbiome Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Microbiome Revenue, 2019-2030
6.5.2 China Cancer Microbiome Market Size, 2019-2030
6.5.3 Japan Cancer Microbiome Market Size, 2019-2030
6.5.4 South Korea Cancer Microbiome Market Size, 2019-2030
6.5.5 Southeast Asia Cancer Microbiome Market Size, 2019-2030
6.5.6 India Cancer Microbiome Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cancer Microbiome Revenue, 2019-2030
6.6.2 Brazil Cancer Microbiome Market Size, 2019-2030
6.6.3 Argentina Cancer Microbiome Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Microbiome Revenue, 2019-2030
6.7.2 Turkey Cancer Microbiome Market Size, 2019-2030
6.7.3 Israel Cancer Microbiome Market Size, 2019-2030
6.7.4 Saudi Arabia Cancer Microbiome Market Size, 2019-2030
6.7.5 UAE Cancer Microbiome Market Size, 2019-2030
7 Cancer Microbiome Companies Profiles
7.1 CD Genomics
7.1.1 CD Genomics Company Summary
7.1.2 CD Genomics Business Overview
7.1.3 CD Genomics Cancer Microbiome Major Product Offerings
7.1.4 CD Genomics Cancer Microbiome Revenue in Global Market (2019-2024)
7.1.5 CD Genomics Key News & Latest Developments
7.2 Eurofins Scientific
7.2.1 Eurofins Scientific Company Summary
7.2.2 Eurofins Scientific Business Overview
7.2.3 Eurofins Scientific Cancer Microbiome Major Product Offerings
7.2.4 Eurofins Scientific Cancer Microbiome Revenue in Global Market (2019-2024)
7.2.5 Eurofins Scientific Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Cancer Microbiome Major Product Offerings
7.3.4 Illumina Cancer Microbiome Revenue in Global Market (2019-2024)
7.3.5 Illumina Key News & Latest Developments
7.4 Prescient Medicine Holding
7.4.1 Prescient Medicine Holding Company Summary
7.4.2 Prescient Medicine Holding Business Overview
7.4.3 Prescient Medicine Holding Cancer Microbiome Major Product Offerings
7.4.4 Prescient Medicine Holding Cancer Microbiome Revenue in Global Market (2019-2024)
7.4.5 Prescient Medicine Holding Key News & Latest Developments
7.5 Micronoma
7.5.1 Micronoma Company Summary
7.5.2 Micronoma Business Overview
7.5.3 Micronoma Cancer Microbiome Major Product Offerings
7.5.4 Micronoma Cancer Microbiome Revenue in Global Market (2019-2024)
7.5.5 Micronoma Key News & Latest Developments
7.6 Novogene
7.6.1 Novogene Company Summary
7.6.2 Novogene Business Overview
7.6.3 Novogene Cancer Microbiome Major Product Offerings
7.6.4 Novogene Cancer Microbiome Revenue in Global Market (2019-2024)
7.6.5 Novogene Key News & Latest Developments
7.7 Oxford Nanopore Technologies
7.7.1 Oxford Nanopore Technologies Company Summary
7.7.2 Oxford Nanopore Technologies Business Overview
7.7.3 Oxford Nanopore Technologies Cancer Microbiome Major Product Offerings
7.7.4 Oxford Nanopore Technologies Cancer Microbiome Revenue in Global Market (2019-2024)
7.7.5 Oxford Nanopore Technologies Key News & Latest Developments
7.8 Pacific Biosciences
7.8.1 Pacific Biosciences Company Summary
7.8.2 Pacific Biosciences Business Overview
7.8.3 Pacific Biosciences Cancer Microbiome Major Product Offerings
7.8.4 Pacific Biosciences Cancer Microbiome Revenue in Global Market (2019-2024)
7.8.5 Pacific Biosciences Key News & Latest Developments
7.9 Qiagen
7.9.1 Qiagen Company Summary
7.9.2 Qiagen Business Overview
7.9.3 Qiagen Cancer Microbiome Major Product Offerings
7.9.4 Qiagen Cancer Microbiome Revenue in Global Market (2019-2024)
7.9.5 Qiagen Key News & Latest Developments
7.10 Therma Fisher Scientific
7.10.1 Therma Fisher Scientific Company Summary
7.10.2 Therma Fisher Scientific Business Overview
7.10.3 Therma Fisher Scientific Cancer Microbiome Major Product Offerings
7.10.4 Therma Fisher Scientific Cancer Microbiome Revenue in Global Market (2019-2024)
7.10.5 Therma Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Microbiome Market Opportunities & Trends in Global Market
Table 2. Cancer Microbiome Market Drivers in Global Market
Table 3. Cancer Microbiome Market Restraints in Global Market
Table 4. Key Players of Cancer Microbiome in Global Market
Table 5. Top Cancer Microbiome Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Cancer Microbiome Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Cancer Microbiome Revenue Share by Companies, 2019-2024
Table 8. Global Companies Cancer Microbiome Product Type
Table 9. List of Global Tier 1 Cancer Microbiome Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Microbiome Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cancer Microbiome Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Cancer Microbiome Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Cancer Microbiome Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Cancer Microbiome Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Cancer Microbiome Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Cancer Microbiome Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Cancer Microbiome Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Cancer Microbiome Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Cancer Microbiome Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Cancer Microbiome Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Cancer Microbiome Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Cancer Microbiome Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Cancer Microbiome Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Cancer Microbiome Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Cancer Microbiome Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Cancer Microbiome Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Cancer Microbiome Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Cancer Microbiome Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Cancer Microbiome Revenue, (US$, Mn), 2025-2030
Table 30. CD Genomics Company Summary
Table 31. CD Genomics Cancer Microbiome Product Offerings
Table 32. CD Genomics Cancer Microbiome Revenue (US$, Mn) & (2019-2024)
Table 33. CD Genomics Key News & Latest Developments
Table 34. Eurofins Scientific Company Summary
Table 35. Eurofins Scientific Cancer Microbiome Product Offerings
Table 36. Eurofins Scientific Cancer Microbiome Revenue (US$, Mn) & (2019-2024)
Table 37. Eurofins Scientific Key News & Latest Developments
Table 38. Illumina Company Summary
Table 39. Illumina Cancer Microbiome Product Offerings
Table 40. Illumina Cancer Microbiome Revenue (US$, Mn) & (2019-2024)
Table 41. Illumina Key News & Latest Developments
Table 42. Prescient Medicine Holding Company Summary
Table 43. Prescient Medicine Holding Cancer Microbiome Product Offerings
Table 44. Prescient Medicine Holding Cancer Microbiome Revenue (US$, Mn) & (2019-2024)
Table 45. Prescient Medicine Holding Key News & Latest Developments
Table 46. Micronoma Company Summary
Table 47. Micronoma Cancer Microbiome Product Offerings
Table 48. Micronoma Cancer Microbiome Revenue (US$, Mn) & (2019-2024)
Table 49. Micronoma Key News & Latest Developments
Table 50. Novogene Company Summary
Table 51. Novogene Cancer Microbiome Product Offerings
Table 52. Novogene Cancer Microbiome Revenue (US$, Mn) & (2019-2024)
Table 53. Novogene Key News & Latest Developments
Table 54. Oxford Nanopore Technologies Company Summary
Table 55. Oxford Nanopore Technologies Cancer Microbiome Product Offerings
Table 56. Oxford Nanopore Technologies Cancer Microbiome Revenue (US$, Mn) & (2019-2024)
Table 57. Oxford Nanopore Technologies Key News & Latest Developments
Table 58. Pacific Biosciences Company Summary
Table 59. Pacific Biosciences Cancer Microbiome Product Offerings
Table 60. Pacific Biosciences Cancer Microbiome Revenue (US$, Mn) & (2019-2024)
Table 61. Pacific Biosciences Key News & Latest Developments
Table 62. Qiagen Company Summary
Table 63. Qiagen Cancer Microbiome Product Offerings
Table 64. Qiagen Cancer Microbiome Revenue (US$, Mn) & (2019-2024)
Table 65. Qiagen Key News & Latest Developments
Table 66. Therma Fisher Scientific Company Summary
Table 67. Therma Fisher Scientific Cancer Microbiome Product Offerings
Table 68. Therma Fisher Scientific Cancer Microbiome Revenue (US$, Mn) & (2019-2024)
Table 69. Therma Fisher Scientific Key News & Latest Developments
List of Figures
Figure 1. Cancer Microbiome Segment by Type in 2023
Figure 2. Cancer Microbiome Segment by Application in 2023
Figure 3. Global Cancer Microbiome Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cancer Microbiome Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cancer Microbiome Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Microbiome Revenue in 2023
Figure 8. By Type - Global Cancer Microbiome Revenue Market Share, 2019-2030
Figure 9. By Application - Global Cancer Microbiome Revenue Market Share, 2019-2030
Figure 10. By Type - Global Cancer Microbiome Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Cancer Microbiome Revenue Market Share, 2019-2030
Figure 12. By Application - Global Cancer Microbiome Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Cancer Microbiome Revenue Market Share, 2019-2030
Figure 14. By Region - Global Cancer Microbiome Revenue Market Share, 2019-2030
Figure 15. By Country - North America Cancer Microbiome Revenue Market Share, 2019-2030
Figure 16. US Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Cancer Microbiome Revenue Market Share, 2019-2030
Figure 20. Germany Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 21. France Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Cancer Microbiome Revenue Market Share, 2019-2030
Figure 28. China Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 32. India Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Cancer Microbiome Revenue Market Share, 2019-2030
Figure 34. Brazil Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Cancer Microbiome Revenue Market Share, 2019-2030
Figure 37. Turkey Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Cancer Microbiome Revenue, (US$, Mn), 2019-2030
Figure 41. CD Genomics Cancer Microbiome Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Eurofins Scientific Cancer Microbiome Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Illumina Cancer Microbiome Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Prescient Medicine Holding Cancer Microbiome Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Micronoma Cancer Microbiome Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Novogene Cancer Microbiome Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Oxford Nanopore Technologies Cancer Microbiome Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Pacific Biosciences Cancer Microbiome Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Qiagen Cancer Microbiome Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Therma Fisher Scientific Cancer Microbiome Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
